🇺🇸 FDA
Patent

US 8747845

Methods of treatment by administering antibodies that bind colony stimulating factor 1 receptor (CSF1R)

granted A61KA61K39/3955A61K39/39558

Quick answer

US patent 8747845 (Methods of treatment by administering antibodies that bind colony stimulating factor 1 receptor (CSF1R)) held by Five Prime Therapeutics, Inc. expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Five Prime Therapeutics, Inc.
Grant date
Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K39/3955, A61K39/39558, A61K45/06, A61P